These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052 [TBL] [Abstract][Full Text] [Related]
7. Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression. Le Grand JN; Gonzalez-Cano L; Pavlou MA; Schwamborn JC Cell Mol Life Sci; 2015 Feb; 72(4):773-97. PubMed ID: 25403878 [TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Lee VM; Trojanowski JQ Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225 [TBL] [Abstract][Full Text] [Related]
10. New therapeutic approaches to Parkinson's disease including neural transplants. Kuan WL; Barker RA Neurorehabil Neural Repair; 2005 Sep; 19(3):155-81. PubMed ID: 16093408 [TBL] [Abstract][Full Text] [Related]
11. Viral vectors, animal models and new therapies for Parkinson's disease. Schneider B; Zufferey R; Aebischer P Parkinsonism Relat Disord; 2008; 14 Suppl 2():S169-71. PubMed ID: 18585946 [TBL] [Abstract][Full Text] [Related]
12. α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease. Bellucci A; Navarria L; Zaltieri M; Missale C; Spano P Brain Res; 2012 Jan; 1432():95-113. PubMed ID: 22153624 [TBL] [Abstract][Full Text] [Related]
13. A new perspective in Parkinson's disease, chaperone-mediated autophagy. Li B; Zhang Y; Yuan Y; Chen N Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675 [TBL] [Abstract][Full Text] [Related]
14. Pluripotent stem cells as new drugs? The example of Parkinson's disease. Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880 [TBL] [Abstract][Full Text] [Related]